(R)-2-(6-(5-chloro-2-(tetrahydro-2H-pyran-4-ylamino)pyrimidin-4-yl)-1-oxoisoindolin-2-yl)-N-((S)-2-hydroxy-1-(6-(4-methylpiperazin-1-yl)pyridin-2-yl)ethyl)propanamide

ID: ALA4856124

PubChem CID: 129053409

Max Phase: Preclinical

Molecular Formula: C32H39ClN8O4

Molecular Weight: 635.17

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C[C@H](C(=O)N[C@H](CO)c1cccc(N2CCN(C)CC2)n1)N1Cc2ccc(-c3nc(NC4CCOCC4)ncc3Cl)cc2C1=O

Standard InChI:  InChI=1S/C32H39ClN8O4/c1-20(30(43)37-27(19-42)26-4-3-5-28(36-26)40-12-10-39(2)11-13-40)41-18-22-7-6-21(16-24(22)31(41)44)29-25(33)17-34-32(38-29)35-23-8-14-45-15-9-23/h3-7,16-17,20,23,27,42H,8-15,18-19H2,1-2H3,(H,37,43)(H,34,35,38)/t20-,27-/m1/s1

Standard InChI Key:  FOWKCJGRLFZWNL-NFQMXDRXSA-N

Molfile:  

 
     RDKit          2D

 45 50  0  0  0  0  0  0  0  0999 V2000
   25.8117  -28.0855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5282  -27.6722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5253  -26.8417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.8099  -26.4325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0970  -27.6726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0982  -26.8438    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3102  -26.5863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.8219  -27.2563    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.3082  -27.9275    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2397  -28.0828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2397  -28.9089    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9540  -29.3202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6687  -28.9065    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.6648  -28.0772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9499  -27.6697    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.3771  -27.6611    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.0937  -28.0700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0931  -28.8963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.8055  -29.3050    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5204  -28.8924    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.5181  -28.0665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.8011  -27.6531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9969  -27.2551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5856  -26.5400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7606  -26.5388    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.9991  -25.8262    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.5255  -29.3218    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   24.0521  -28.7117    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.5834  -27.9689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3470  -27.2527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5220  -27.2515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7584  -27.9678    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3449  -28.6816    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.1148  -26.5351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2905  -26.5335    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8762  -27.2479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2920  -27.9654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1149  -27.9634    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.8833  -28.6828    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.0574  -28.6824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6465  -29.3937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0569  -30.1097    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.8829  -30.1100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2983  -29.3943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6432  -30.8235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  5  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  2 10  1  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 17 22  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
  8 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  2  0
 11 27  1  0
  9 28  2  0
 23 29  1  6
 25 30  1  0
 30 31  1  0
 30 32  1  6
 32 33  1  0
 31 34  2  0
 34 35  1  0
 35 36  2  0
 36 37  1  0
 37 38  2  0
 38 31  1  0
 39 40  1  0
 39 44  1  0
 40 41  1  0
 41 42  1  0
 42 43  1  0
 43 44  1  0
 37 39  1  0
 42 45  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4856124

    ---

Associated Targets(Human)

MAPK1 Tchem MAP kinase ERK2 (25055 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A-375 (9258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
COLO 205 (50209 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 635.17Molecular Weight (Monoisotopic): 634.2783AlogP: 2.73#Rotatable Bonds: 9
Polar Surface Area: 136.05Molecular Species: NEUTRALHBA: 10HBD: 3
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.97CX Basic pKa: 7.53CX LogP: 1.97CX LogD: 1.60
Aromatic Rings: 3Heavy Atoms: 45QED Weighted: 0.32Np Likeness Score: -1.06

References

1. Heightman TD, Berdini V, Bevan L, Buck IM, Carr MG, Courtin A, Coyle JE, Day JEH, East C, Fazal L, Griffiths-Jones CM, Howard S, Kucia-Tran J, Martins V, Muench S, Munck JM, Norton D, O'Reilly M, Palmer N, Pathuri P, Peakman TM, Reader M, Rees DC, Rich SJ, Shah A, Wallis NG, Walton H, Wilsher NE, Woolford AJ, Cooke M, Cousin D, Onions S, Shannon J, Watts J, Murray CW..  (2021)  Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2.,  64  (16.0): [PMID:34387469] [10.1021/acs.jmedchem.1c00905]

Source